SINOVAC BIOTECH LTD (SVA) Free cash flow 2016–2025
SINOVAC BIOTECH LTD (SVA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$561.1MFY2025 · since FY2016: -$26.6M → -$561.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$561.1M | -267.1% |
| FY2024 | -$152.9M | -772.4% |
| FY2023 | -$17.5M | +98.4% |
| FY2022 | -$1.1B | -107.6% |
| FY2021 | $14.7B | +4086.1% |
| FY2020 | $351.8M | +1136.8% |
| FY2019 | $28.4M | +1120.9% |
| FY2018 | $2.3M | -95.1% |
| FY2017 | $47.8M | +280.2% |
| FY2016 | -$26.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice